Protara Therapeutics, Inc.TARANASDAQ
LOADING
|||
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 11.38% |
| Q2 2025 | -25.57% |
| Q1 2025 | 6.70% |
| Q4 2024 | -13.82% |
| Q3 2024 | -17.93% |
| Q2 2024 | 14.26% |
| Q1 2024 | -8.55% |
| Q4 2023 | -3.66% |
| Q3 2023 | 12.70% |
| Q2 2023 | -24.86% |
| Q1 2023 | 76.79% |
| Q4 2022 | -406.66% |
| Q3 2022 | 9.93% |
| Q2 2022 | 20.60% |
| Q1 2022 | -5.15% |
| Q4 2021 | 5.09% |
| Q3 2021 | 15.69% |
| Q2 2021 | 5.07% |
| Q1 2021 | -52.88% |
| Q4 2020 | -10.51% |
| Q3 2020 | -11.62% |
| Q2 2020 | 29.03% |
| Q1 2020 | -489.17% |
| Q4 2019 | 209.81% |
| Q3 2019 | -64.77% |
| Q2 2019 | 6.50% |
| Q1 2019 | -8.61% |
| Q4 2018 | 68.80% |
| Q3 2018 | 7.58% |
| Q2 2018 | 19.74% |
| Q1 2018 | -9.55% |
| Q4 2017 | 54.91% |
| Q3 2017 | -119.43% |
| Q2 2017 | 13.69% |
| Q1 2017 | 6.61% |
| Q4 2016 | 2.11% |
| Q3 2016 | 10.11% |
| Q2 2016 | -20.76% |
| Q1 2016 | -3.31% |
| Q4 2015 | -17.84% |